Rufinamide
NDC 68180-797, Rufinamide, suspension, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 68180-797
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213457
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68180-797 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RUFINAMIDE40 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68180-797-01 | 68180079701 | 1 BOTTLE in 1 CARTON (68180-797-01) / 460 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1e671632-d5bd-499a-ba06-0d1dc0d99622NADAC price for package 68180079701
GET /v1/drugs/nadac/68180079701
Use it
Look up 68180-797 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68180-797 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68180-797. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.